King D J
Avian Dis. 1984 Apr-Jun;28(2):504-13.
A total of 166 infectious bronchitis virus (IBV) hemagglutination (HA) antigen preparations were made during a 30-month period from allanto-amnionic fluid (AAF) from chicken embryos inoculated with 10 different IBV strains (Mass 41, Conn 46, H52, Florida 18288, Ark 99, JMK, T, Holte, EF, SE17). Antigens were prepared by inoculating 9- or 10-day-old embryos with 10(5.0) to 10(6.5) EID50 IBV, harvesting AAF after a 30-hour-postinoculation incubation, and phospholipase C (PLC) treatment of virus concentrated by pelleting from the AAF. Longer (48 hr) incubation times were tried, but production of H52 HA antigen was successful only from AAF harvested after 30 hours of incubation. AAF from JMK-infected embryos had lower infectivity titers and frequently yielded lower HA antigen titers than the other strains. The treatment of AAF with fluorocarbon did not enhance or diminish HA activity but did yield clearer antigens by removing extraneous material. Polyethylene glycol precipitation of virus was an acceptable alternative to pelleting virus at 39,000 X g. Inactivation of IBV with 0.1% betapropiolactone did not affect HA activity, whereas inactivation with 0.1% formalin caused a marked reduction in HA titer. Different buffer formulations including phosphate, tris, or HEPES were tried to optimize the conditions for PLC treatment of virus concentrate, but there were no apparent differences in the antigens prepared in the different buffers. The HA antigen preparations were stored and were stable at 4 C. Antigen titers of greater than or equal to 64 after storage for 20 months or longer were not uncommon. Addition of merthiolate as a preservative had no deleterious effect on HA activity. Antigen stability appeared to be enhanced by incorporating EDTA in buffer for virus pellet recovery and during enzyme treatment. Attempts to produce HA antigens from cell-culture-adapted virus propagated in chicken kidney cells were less satisfactory. An acceptable HA antigen was prepared from only two (Mass 41, SE17) of the seven strains that were tried. Virus propagation in chicken embryos is the better method of the two for IBV HA antigen production. Aside from the need to concentrate virus and treat the concentrate with PLC, there appeared to be considerable latitude in the procedures that can be used to make acceptable IBV HA antigens.
在30个月的时间里,从接种了10种不同传染性支气管炎病毒(IBV)毒株(Mass 41、Conn 46、H52、Florida 18288、Ark 99、JMK、T、Holte、EF、SE17)的鸡胚尿囊 - 羊膜液(AAF)中制备了总共166份IBV血凝素(HA)抗原制剂。通过用10(5.0)至10(6.5) EID50的IBV接种9日龄或10日龄胚胎,接种后孵育30小时收获AAF,并对通过从AAF中离心沉淀浓缩的病毒进行磷脂酶C(PLC)处理来制备抗原。尝试了更长(48小时)的孵育时间,但仅从孵育30小时后收获的AAF成功制备了H52 HA抗原。来自JMK感染胚胎的AAF感染性滴度较低,并且与其他毒株相比,其HA抗原滴度通常也较低。用氟碳处理AAF不会增强或降低HA活性,但通过去除杂质确实产生了更清亮的抗原。病毒的聚乙二醇沉淀是在39,000×g下离心沉淀病毒的一种可接受的替代方法。用0.1%β - 丙内酯灭活IBV不影响HA活性,而用0.1%福尔马林灭活会导致HA滴度显著降低。尝试了包括磷酸盐、Tris或HEPES在内的不同缓冲液配方以优化PLC处理病毒浓缩物的条件,但在不同缓冲液中制备的抗原没有明显差异。HA抗原制剂在4℃储存且稳定。储存20个月或更长时间后抗原滴度大于或等于64并不罕见。添加硫柳汞作为防腐剂对HA活性没有有害影响。在用于回收病毒沉淀的缓冲液以及酶处理过程中加入EDTA似乎增强了抗原稳定性。尝试从在鸡肾细胞中增殖的细胞培养适应病毒制备HA抗原的效果不太理想。在所尝试的7种毒株中,仅从两种(Mass 41、SE17)制备出了可接受的HA抗原。对于IBV HA抗原生产而言,在鸡胚中进行病毒增殖是两种方法中较好的一种。除了需要浓缩病毒并用PLC处理浓缩物外,在用于制备可接受的IBV HA抗原的程序方面似乎有相当大的灵活性。